Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — Q2 FY24 Earnings Presentation
27 slides from Nath Bio-genes (india)'s earnings presentation, Oct 16, 2023
Slide 1: Cover letter to stock exchanges on results presentation
16th October 2023 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation
Slide 2: Q2FY24 Investor Presentation
Nath Bio-Genes (I) Limited Q2FY24 Investor Presentation 1
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Strategy for Sustainable Value Creation
Strategy for Sustainable Value Creation 1 2 3 4 INVESTMENT TAILOR MADE PRODUCT STRONG R&D PRODUCTS PERFORMANCE FOCUS GRADE . BALANCE SHEET Customized High Yield and Bio-tech integrated Zero Long Term products to address Strong Pest and innovation Debt key farmers’ Disease Resistance requirements 3
Slide 5: Competitive Positioning in a Tough Sector
Competitive Positioning in a Tough Sector Focus Area Product Selection • Build a dream-product basket with superior and diversified products • Build an Un-paralleled Supply Chain Network Winning Strategies • Focus on Cotton, Vegetables, Fodder Bajra • Empower Stakeholders; Build long-term, loyal, sy
Slide 6: What our Business Delivered in Last 6 Years
What our Business Delivered in Last 6 Years Average Selling Price (Rs/kg) is Increasing Revenue Growth (INR Cr) 1311 CAG 9.4% 301 192 480 209 128 FY18 FY23 Field Crops Vegetables FY18 FY23 5
Slide 7: Tailor Made Products
Tailor Made Products Understand key farmer Develop products to Focus on disease and Stringent multistage requirements based on suit various agri climatic pest resistance which trials before commercial deep market research conditions automatically results in development higher yield 6
Slide 8: Focused on R&D
Focused on R&D ▪ Produce Genetically Pure and Premium Quality Seeds ▪ Prioritise Disease and Pest resistance breeding ▪ Well Invested, DSIR recognized R&D Innovation Centers ▪ Cold storage facilities, warehouses, and conditioning godowns having a capacity of 25,000MT ▪ R&D Team of experienced scient
Slide 9: Focused on Shareholder Value Creation
Focused on Shareholder Value Creation Growing Business Product Excellence Strong Positions in important crops Innovation and solution that drive productivity and create value for farmers Differentiated Customer Experience Margin Expansion Expanding market reach through new and innovative products su
Slide 10: Our Success Stories
Our Success Stories Akhand Tomato Nath Sanket Super-27 Bajra 9
Slide 11: Nath Sanket – #1 BT Cotton Hybrid
Nath Sanket – #1 BT Cotton Hybrid Overview and Outlook Market Need: ▪ High level of resistance to sucking pest ▪ Leading BT-Cotton hybrid in the Market ▪ Yield losses ▪ Most preferred hybrid resistant to pink bollworm. What our R&D Produced: ▪ Less input cost with higher output. ▪ Worked with highly
Slide 12: Testimonials: Nath Sanket
| Testimonials: Nath Sanket ~ $2 3) red iN oa ‘ae! Hebd Ae Veo Haeaed HUET Vac 21 wa ead dt Ae TATer Just ect eI foe ed VT & ofa wectefict alot & wrevr carseat wT waufeedcar.. ey . NBC 1111 BG Il Cotton Hye Seeds with Bogard Technology
Slide 13: Super 27- Deep-Rooting into Bajra
Super 27- Deep-Rooting into Bajra Overview and Outlook Market Need ▪ High Yielding dual Purpose Hybrids ▪ Product is seeing strong traction. ▪ Crop window exploitation ▪ Tall plant size without lodging problem ▪ Dual purpose – grain and fodder Our R&D efforts ▪ Addressable market of 3000 tons ▪ NBIL
Slide 14: Farmers on Super-27
Farmers on “Super-27” ‘Bel WT Tate FUe-27 Vw Teeaed ase 2. serb fale ole vd asigd @ ste sus aft Haeaed facta &. Jom w emer are & fare aft TerHsgM WME...
Slide 15: Akhand- Best Performing Hybrid Tomato Seeds
Akhand- Best Performing Hybrid Tomato Seeds Market Need Overview and Outlook ▪ Very deep red colour fruits with better shelf life ▪ Virus resistant hybrid ▪ Strong demand seen in the market ▪ Higher Yield ▪ Addressable market size of Rs 150 cr. ▪ Firm fruit fit for long transportation. Our R&D Effor
Slide 16: Testimonials: Akhand
a Testimonials: Akhand > | Farmers on “Akhand” onal tht feds UH aedetot cace VsMctt , fied her sare Tee ect ST th eld e. hel Be Ud agg Aol h orev wes Ufeceot hee sugw e site sus ever aft Faved e. AKHAND (nt#-1912) a
Slide 17: Q2FY24 Performance
Q2FY24 PERFORMANCE 16
Slide 18: Key Operating and Financial Highlights
Key Operating and Financial Highlights Operating Performance ▪ Revenue growth of 11.6% in H1FY24 compared to H1FY23; ▪ Cotton volumes increased by 17%. ▪ Paddy volumes increased by 32.30% while, paddy sales value grew by 39.62%,highlighting increased Hybrid paddy’s share in product mix. ▪ Bajra segm
Slide 19: Segmental Revenue Contribution
Segmental Revenue Contribution H1FY24 Revenue H1FY23 Revenue INR 2,578 Mn INR 2,310Mn Cotton,32% Cotton, 36% Others,39% Others, 41% Paddy, 23% Paddy ,29% Cotton Paddy Others Cotton Paddy Others • Others include: Jowar, Bajra, Maize, Mustard, Wheat 18
Slide 20: Segment wise Operating Performance
Segment wise Operating Performance Products UoM H1FY24 H1FY23 YOY Growth FY23 Packets in Cotton 13.10 11.17 17.2% 13.80 lakhs Paddy Quintals 53,901 40,730 32.30% 54,779 Other Crops Quintals 20,684 21,428 -3.50% 43,483 Plant Nutrient (WCW) Liters 24,872 20,252 22.8% 33,625 19
Slide 21: Income Statement
Income Statement Particulars (INR Mn) H1FY24 H1FY23 %Change (YoY) Total Revenue 2,578 2,310 11.6% Gross Profit 1,359 1,227 10.7% Gross Margin (%) 52.7% 53.1% EBITDA 421 392 7.4% EBITDA Margin (%) 16.3% 17% Depreciation 15 13 15.3% Finance Cost 52 56 -7.4% PBT 356 325 9.5% Tax Rate (%) 1.59% 0.7% PAT
Slide 22: Appendix
APPENDIX 21
Slide 23: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet 888 Net Debt (INR Mn) Net Worth (INR Mn) 679 672 6133 659 5576 5420 5734 576 5076 4692 478 363 3033 207 1071 1213 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 -121 EBITDA Margin (%) PAT Margin (%) 22% 18% 18
Slide 24: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent Mr. N Kagliwal Mr. Satish Kagliwal MD Chairman Leadership Team Mr. Devinder Khurana Dr S Raina Dr VN Kulkarni Mr K Reddy Harish Pandey CFO Head – Genetic Research Head- R & D Head – Supply Chain Business Lead Nath Promoters are committed to sustainabl
Slide 25: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY23 FY22 FY21 FY20 Total Revenue 3,013 2,783 3,076 2,799 Gross Profit 1,668 1,544 1,715 1,536 Gross Margin (%) 55% 56% 56% 55% EBITDA 489 373 667 547 EBITDA Margin (%) 16% 13% 22% 20% Depreciation 30 31 28 14 Finance Cos
Slide 26: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn)FY FY23 FY22 FY21 FY20 Liabilities FY23 FY22 FY21 FY20 Fixed Assets 2,444 2,449 2,469 2,460 Share Capital 190 190 190 190 Financial Assets 51 51 53 52 Reserves & Surplus 5,544 5,230 5,943 5,386 Other Non-current Assets 225 218 134 15 Long-Term Borrowings 4 7 7
Slide 27: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja sheetal@GoIndiaadvisors.com M:+91 97693 64166 Deepika Sharma deepika@GoIndiaadvisors.com M:+918451029510 26
Nath Bio-Genes (India) — Q2 FY24 Earnings Presentation on 6ix